A PHASE 2 TRIAL OF SALVAGE TREATMENT WITH GEMCITABINE AND S-1 COMBINATION IN HEAVILY PRETREATED PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Sym, S. J. [1 ]
Hong, J. [1 ]
Ahn, H. K. [1 ]
Park, J. [1 ]
Cho, E. K. [1 ]
Lee, J. H. [1 ]
Lee, W. [2 ]
Baek, J. [2 ]
Park, Y. H. [2 ]
Shin, D. B. [1 ]
机构：
[1] Gachon Univ, Gil Hosp, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea
[2] Gachon Univ, Gil Hosp, Dept Gen Surg, Inchon, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
10.1016/S0959-8049(13)70005-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AOSOP5
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Kim, Hyeong Su
    Kim, Ho Young
    Zang, Dae Young
    Oh, Ho Suk
    Jeon, Jang Yong
    Cho, Ji Woong
    Park, Choong Kee
    Kim, Jong Hyeok
    Kim, Min-Jeong
    Ha, Hong Il
    Kim, Jung Han
    Han, Boram
    Song, Hunho
    Kwon, Jung Hye
    Choi, Dae Ro
    Jung, Joo Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 711 - 718
  • [22] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
    Hyeong Su Kim
    Ho Young Kim
    Dae Young Zang
    Ho Suk Oh
    Jang Yong Jeon
    Ji Woong Cho
    Choong Kee Park
    Jong Hyeok Kim
    Min-Jeong Kim
    Hong Il Ha
    Jung Han Kim
    Boram Han
    Hunho Song
    Jung Hye Kwon
    Dae Ro Choi
    Joo Young Jung
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
  • [23] Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience
    de Lima Araujo, Luiz Henrique
    Moitinho, Marcos Veloso
    Fantini Silva, Ana Maria
    Sousa Gomes, Cleudes Alice
    Noronha, Helio, Jr.
    MEDICAL ONCOLOGY, 2011, 28 : S2 - S7
  • [24] Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience
    Luiz Henrique de Lima Araújo
    Marcos Veloso Moitinho
    Ana Maria Fantini Silva
    Cleudes Alice Sousa Gomes
    Hélio Noronha Júnior
    Medical Oncology, 2011, 28 : 2 - 7
  • [25] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Pin Zhang
    Zhongsheng Tong
    Fuguo Tian
    Yongsheng Wang
    Junlan Yang
    Weilian Li
    Lijun Di
    Wei Liu
    Li Tang
    Rongguo Qiu
    Binghe Xu
    Journal of Hematology & Oncology, 9
  • [26] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Zhang, Pin
    Tong, Zhongsheng
    Tian, Fuguo
    Wang, Yongsheng
    Yang, Junlan
    Li, Weilian
    Di, Lijun
    Liu, Wei
    Tang, Li
    Qiu, Rongguo
    Xu, Binghe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [27] Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
    Liu, Xiu
    Ma, Xiaoting
    Ou, Kai
    Wang, Qi
    Gao, Lizhen
    Yang, Lin
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 277 - 289
  • [28] Phase Ⅰ trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Akinori Watanabe
    Mitsuhiro Kida
    Shiro Miyazawa
    Tomohisa Iwai
    Kosuke Okuwaki
    Toru Kaneko
    Hiroshi Yamauchi
    Miyoko Takezawa
    Hiroshi Imaizumi
    Wasaburo Koizumi
    World Journal of Gastroenterology, 2015, (19) : 5979 - 5984
  • [29] A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Chou, Wen-Chi
    Kuan, Feng-Che
    Lee, Kuan-Der
    Rau, Kun-Ming
    Huang, En-Seng
    Yang, Tsai-Sheng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6061 - 6070
  • [30] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
12345